Sex differences in cancer outcomes across the range of eGFR.
Richard ShemiltMichael K SullivanPeter HanlonBhautesh Dinesh JaniNicole Louise De La MataBrenda RosalesBenjamin M P ElyanJames A HedleyRachel B CuttingMelanie L R WyldDavid A McAllisterAngela C WebsterPatrick B MarkJennifer Susan LeesPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
Lower or higher eGFR was not associated with substantially higher odds of presenting with advanced cancer across most cancer sites, but was associated with reduced survival. A stronger assocation with all-cause mortality in females compared to males with eGFR < 30 is concerning and warrants further scrutiny.